NCT01968980 · Interventional trial
A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia
Overall registry status Completed
Phase 3
Conditions Heterozygous Familial Hypercholesterolemia
Delaware Valley sites
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory